ATE306267T1 - Kombinationsbehandlung bei akutem myokardinfarkt - Google Patents

Kombinationsbehandlung bei akutem myokardinfarkt

Info

Publication number
ATE306267T1
ATE306267T1 AT03700828T AT03700828T ATE306267T1 AT E306267 T1 ATE306267 T1 AT E306267T1 AT 03700828 T AT03700828 T AT 03700828T AT 03700828 T AT03700828 T AT 03700828T AT E306267 T1 ATE306267 T1 AT E306267T1
Authority
AT
Austria
Prior art keywords
myocardial infarction
acute myocardial
combination treatment
combination
treatment
Prior art date
Application number
AT03700828T
Other languages
English (en)
Inventor
Pentti Poeder
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE306267T1 publication Critical patent/ATE306267T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AT03700828T 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt ATE306267T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon
PCT/FI2003/000078 WO2003063870A1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction

Publications (1)

Publication Number Publication Date
ATE306267T1 true ATE306267T1 (de) 2005-10-15

Family

ID=8563019

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03700828T ATE306267T1 (de) 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt

Country Status (19)

Country Link
US (1) US20050255096A1 (de)
EP (1) EP1478362B1 (de)
JP (1) JP2005516050A (de)
CN (1) CN1291718C (de)
AT (1) ATE306267T1 (de)
AU (1) AU2003201980B2 (de)
BR (1) BR0307317A (de)
CA (1) CA2474430C (de)
DE (1) DE60301862T2 (de)
DK (1) DK1478362T3 (de)
ES (1) ES2249707T3 (de)
FI (1) FI20020197A0 (de)
HK (1) HK1077215A1 (de)
IL (1) IL163091A (de)
MX (1) MXPA04007345A (de)
NZ (1) NZ534221A (de)
PL (1) PL212241B1 (de)
WO (1) WO2003063870A1 (de)
ZA (1) ZA200406085B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
WO2008082871A1 (en) * 2006-12-28 2008-07-10 Orion Corporation Formulations of levosimendan for parenteral administration
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5626601A (en) * 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties

Also Published As

Publication number Publication date
WO2003063870A1 (en) 2003-08-07
NZ534221A (en) 2007-06-29
MXPA04007345A (es) 2004-11-26
CN1291718C (zh) 2006-12-27
PL371741A1 (en) 2005-06-27
IL163091A (en) 2012-06-28
CN1625398A (zh) 2005-06-08
FI20020197A0 (fi) 2002-02-01
CA2474430C (en) 2010-09-28
ES2249707T3 (es) 2006-04-01
BR0307317A (pt) 2005-01-04
PL212241B1 (pl) 2012-08-31
DK1478362T3 (da) 2005-11-14
CA2474430A1 (en) 2003-08-07
HK1077215A1 (en) 2006-02-10
EP1478362B1 (de) 2005-10-12
JP2005516050A (ja) 2005-06-02
DE60301862T2 (de) 2006-07-20
US20050255096A1 (en) 2005-11-17
AU2003201980B2 (en) 2006-12-07
EP1478362A1 (de) 2004-11-24
DE60301862D1 (de) 2006-02-23
ZA200406085B (en) 2005-10-06

Similar Documents

Publication Publication Date Title
CY1121113T1 (el) Θεραπεια της νοσου ρομρε
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
DK1173178T3 (da) Præparat, der omfatter apomorfin og sildenafil, og anvendelse deraf til behandling af erektil dysfunktion
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
NO20032027L (no) Effektive antitumorbehandlinger
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
PT1408977E (pt) Terapia de combinacao para o tratamento de falha cardiaca
TW200509909A (en) Use of organic compounds
SI1362590T1 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60111622D1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
DK1239861T3 (da) Kombinationaf cyamemazin og et atypisk neuroleptikum
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
CO5170404A1 (es) Terapia para melanomas
NO20043774L (no) The use of devazenide as analgesic agent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478362

Country of ref document: EP

EEIH Change in the person of patent owner